“With an unprecedented confluence of will, resources and urgency, there has never been a better time to be a science and technology Innovator in Hong Kong. Let’s take this once-in-a-generation opportunity to make a difference”.
Over the last two decades, innovation and entrepreneurship in life sciences and healthcare sectors have been receiving increased attention, both in terms of scholarly research and the number of innovative enterprises. A McKinsey paper states that during the COVID-19 pandemic, the healthcare sector experienced dramatic changes, with novel business models, unexpected collaborations, and accelerated timelines requiring organisations to rethink how they operate. In recent years, to advance the new economy, governments, i.e. Hong Kong, Singapore, and Israel encourage government-industry-academic / research institution collaboration to translate R&D outcomes into business innovations and drive socio-economic impacts, such as enhancing the quality of and access to healthcare.
This hybrid event illustrates successful innovation and entrepreneurship in life sciences and healthcare, as well as inspires young talents to make new breakthroughs to create and transfer knowledge to accelerate the economy and make societal impacts.
Please see the attached flyer for more information.
Registration is online via https://www.livestudio.one/event/register/Online_20230208_TownAndGown
Professor Dennis Lo
Associate Dean (Research), Faculty of Medicine
Chairman, Department of Chemical Pathology
Li Ka Shing Professor of Medicine
Professor of Chemical Pathology
Director, Li Ka Shing Institute of Health Sciences
Director, State Key Laboratory of Translational Oncology
The Chinese University of Hong Kong
Mr. Alvin Cheung
CEO and Co-founder, HandyRehab (Zunosaki)
Innovation Forum Hong Kong - IMAGINE IF! Champion (2017)
Forbes 30 Under 30 – Asia: Healthcare & Science (2021)
This hybrid event aims to converse with Professor Dennis Lo and Mr. Alvin Cheung to elaborate on the following:
Professor Dennis Lo, a molecular biologist, is an important contributor to the development of non-invasive prenatal testing. He is the first to discover the presence of fetal DNA in maternal plasma. His team has developed a non-invasive prenatal diagnostic test for Down Syndrome, and it has been adopted in over 90 countries. Also, his team succeeded in discovering a genome-wide genetic map technology, which enables non-invasive prenatal diagnostic tests to be used for multiple genetic diseases, as well as cancer detection. Professor Lo has received numerous awards, including the King Faisal International Prize in Medicine (2014), the Future Science Prize - Life Science Prize (2016), Royal Medal (2021), and Lasker-DeBakey Clinical Medical Research Award (2022). Professor Dennis Lo is a gifted scientist, as well as a visionary leader and a passionate entrepreneur.
Mr. Alvin Cheung is CEO and Co-founder, HandyRehab (Zunosaki), a robotic technology start-up established in 2015. Its flagship product is a lightweight and wireless robotic glove that can assist with stroke rehabilitation. The Hong Kong-based company has raised undisclosed funding from private investors. It is supported by Hong Kong Science and Technology Parks' incubation programme, as well as Hong Kong-based accelerator - SOW Asia. Its latest product is Temi Medic, a robot assistant developed in Israel that can, among other caregiving services, accommodate virtual visits through video conferencing and monitor patients' blood pressure and temperature. Mr. Alvin Cheung is on a mission to make rehabilitation robotics accessible and affordable to those in need.
Mr. Andy Wong is the Head of Innovation and Technology (I&T) at Invest Hong Kong, the government department responsible for attracting, facilitating and retaining Foreign Direct Investment into Hong Kong. Mr. Wong is the leader of the I&T sector to offer one-stop services to help overseas and Mainland companies to set up and develop businesses in Hong Kong. His key focused technology clusters include biotech, medical devices, healthcare, AI and robotics, microelectronics, new materials, and green technologies. Mr. Wong has wealth strategy consulting and business development experience in the high-tech sector. Before joining Invest Hong Kong, Mr. Wong has held various senior positions at a global leading consulting firm and a global Fortune 500 technology company. Mr. Andy Wong’s expertise spans across corporate strategy, market entry strategy, business development, technology advisory and regulatory support.
Dr. Cecilia Tsui is the Founder and Executive Director, Innovation Forum Hong Kong, which is a base for developing initiatives in Greater China / Asia Pacific for the Global Innovation Forum. She has developed an MBA course on Innovation, Entrepreneurship and Technological Change: Building on Peter Drucker’s Insights with Professor Joseph Maciariello (ally and successor of Peter Drucker). As well, Dr. Tsui is the Founder Chair, Chartered Management Institute Hong Kong, Advisor
(Management Education and Research), MLA Academy (formerly Peter F. Drucker Academy Hong Kong), and a Mentor of the Cambridge Institute for Sustainability Leadership Accelerator Programme. Having worked for multinational corporations, and with extensive experiences in business, education and training, Dr. Cecilia Tsui is keen to promote youth entrepreneurship, to facilitate profitable growth of startups and scaleups, as well as to enrich innovation and entrepreneurship ecosystems for the greater good.
Wednesday, February 08th 2023
10:00 – 11:30 (GMT)